Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

Sanofi image

Setback for Sanofi dengue vaccine

September 13, 2012 Research and Development, Sales and Marketing Dengue fever, Sanofi, Sanofi Pasteur, Vaccine

Sanofi Pasteur’s vaccine for dengue fever has failed to show protection against a key serotype of the potentially fatal illness. …
News
The ABPI has welcomed the announcement

Pharma thumbs-up for government innovation centre

September 12, 2012 Research and Development, Sales and Marketing ABPI, synthetic biology

The announcement of a new innovation and knowledge centre for synthetic biology has been welcomed by pharma groups.The new centre is part …
News
The RNAi therapeutic mechnism

New frontiers in drug discovery

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing RNA, drug discovery, therapeutic

Despite the success of small molecule and biologic drugs such as monoclonal antibodies, there remain many areas of unmet medical …
Feature
dr_brett_haumann

Circassia appoints GSK’s Dr Brett Haumann

September 11, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Brett Haumann, Circassia

Speciality biopharma firm Circassia has announced the appointment of Dr Brett Haumann as chief medical officer. Haumann joins allergy-focussed Circassia …
Appointment
Merck image

Merck releases new Phase III insomnia data

September 11, 2012 Research and Development, Sales and Marketing Merck, insomnia, suvorexant

Merck says it is on course to file its investigational insomnia drug suvorexant in the US by the end of …
News
MedImmune

MedImmune signs China deal

September 11, 2012 Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, China, MedImmune, WuXi, emerging markets, rheumatoid arthritis

MedImmune has sealed a joint venture with Shanghai-based WuXi AppTec to develop a novel biologic for autoimmune and inflammatory diseases …
News
screen_shot_2012-09-10_at_10

Ex-Pfizer head joins Red Door as International director

September 10, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Thomas, Pfizer, Red Door

Andrew Thomas the strategic communications lead for Pfizer’s primary care medicines across Europe and Canada joins Red Door Communications in …
Appointment
lilly corporate hq image

Lilly suffers late-stage cancer blow

September 10, 2012 Research and Development, Sales and Marketing Alimta, Cancer, avastin, lilly, oncology

Eli Lilly suffered a blow to its oncology programme when a new combination treatment failed to improve overall survival in …
News
merck kgaa image

Merck KGaA licences new cancer candidate

September 10, 2012 Research and Development, Sales and Marketing Cancer, EGFR, Merck KGaA, oncology

Merck KGaA has signed a worldwide licence agreement with Danish company Symphogen which could expand its portfolio of drugs targeting …
News

New product launches – maximise your chance of success

September 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MSI, Paul Stuart Kregor, Paul Stuart-Kregor, marketing, product launch

You don’t have to look very far to see that the pharma industry business model is under increased pressure, and …
Feature

Merck KGaA cuts over 10% of German workforce

September 5, 2012 Research and Development

Merck KGaA is to get rid of more than 10% of its workforce in Germany over the next three years …
News

Pharma welcomes Hunt to top health job

September 5, 2012 Research and Development, Sales and Marketing Andrew Lansley, NHS, NHS reform

The ABPI has used health secretary Andrew Lansley’s demotion at prime minister David Cameron’s first major cabinet reshuffle to restate …
News

Pfizer to develop phase II cancer vaccine

September 4, 2012 Research and Development, Sales and Marketing Cancer, Pfizer, VLST, cancer vaccine

Pfizer has licensed a cancer compound which is ready for phase II study from a US firm specialising in cancer …
News

Contract research news in brief

September 4, 2012 Research and Development CRO, Charles River, WuXi

 Charles River Laboratories (CRL) has paid $17 million for Accugenix, a company which provides endotoxin detection and microbial identity testing …
News
Novartis

Novartis cheered by COPD trial results

September 3, 2012 Research and Development COPD, ERS, Novartis

One of Novartis’ experimental respiratory drugs has proved superior in a late-stage trial to Boehringer Ingelheim and Pfizer’s existing brand …
News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026